Cite
Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma.
MLA
Ahmed, Mohammed H., et al. “Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma.” The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, vol. 50, no. 2, Mar. 2023, pp. 234–42. EBSCOhost, https://doi.org/10.1017/cjn.2022.5.
APA
Ahmed, M. H., Hernández-Verdin, I., Bielle, F., Verreault, M., Lerond, J., Alentorn, A., Sanson, M., & Idbaih, A. (2023). Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 50(2), 234–242. https://doi.org/10.1017/cjn.2022.5
Chicago
Ahmed, Mohammed H, Isaias Hernández-Verdin, Franck Bielle, Maïté Verreault, Julie Lerond, Agusti Alentorn, Marc Sanson, and Ahmed Idbaih. 2023. “Expression and Prognostic Value of CD80 and CD86 in the Tumor Microenvironment of Newly Diagnosed Glioblastoma.” The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques 50 (2): 234–42. doi:10.1017/cjn.2022.5.